2m 2m 2m 2m 2m 2m 2m
FOGHORN THERAP (FHTX)
NASDAQ
$3.70+$0.06 (+1.62%)
Price as of Jun 03, 2026 7:54 PM EDT- $251.3MMarket Cap
- -16.74%1-Year Change
- BiotechnologyIndustry
FOGHORN THERAP (FHTX)
$3.70+$0.06 (+1.62%)
FHTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.64 | ||
Change | -$0.34 (-8.68%) | ||
Open | $3.62 | ||
High | $3.68 | ||
Low | $3.54 | ||
Previous Close | $3.63 | ||
Volume | 144,389 | ||
30-Day Average Volume | 164,652 | ||
1-Week Change | -16.93% | ||
1-Month Change | -23.74% | ||
1-Year Change | -16.74% | ||
3-Year Change | -48.87% | ||
5-Year Change | -66.91% | ||
Fundamentals | |||
Shares Outstanding | 58.7M | ||
Total Assets | $222.2M | ||
Market Cap | $251.3M | ||
Enterprise Value | $163.6M | ||
Period: QTR TTM FY | |||
Revenue | $3.3M | ||
Net Income | -$19.9M | ||
Free Cash Flow | -$25.3M | ||
EBIT | -$19.9M | ||
EBITDA | -$19.6M | ||
Net Working Capital | $123.7M | ||
EPS | -$0.29 | ||
Enterprise Value/EBITDA | -8 | ||
Enterprise Value/Revenue | 50 | ||
P/B | -3 | ||
P/E | -15 | ||
PEG | -1 | ||
Price/Free Cash Flow | -10 | ||
Price/Operating Cash Flow | -10 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue